The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when imipramine is combined with doxepin.


The risk or severity of adverse effects can be increased when loteprednol is combined with donepezil.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with malathion.


The risk or severity of adverse effects can be increased when prednisone is combined with mefloquine.


The risk or severity of adverse effects can be increased when imipramine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Propacetamol is combined with loteprednol.


The risk or severity of adverse effects can be increased when betaxolol is combined with diltiazem.


The risk or severity of adverse effects can be increased when nimesulide is combined with estrone.


The risk or severity of adverse effects can be increased when nimesulide is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when nimodipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when pargyline is combined with ritodrine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Bretylium.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with suprofen.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with loteprednol.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with Salmeterol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when nimodipine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with maprotiline.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when morphine is combined with metoprolol.


The risk or severity of adverse effects can be increased when Perospirone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with spironolactone.


The risk or severity of adverse effects can be increased when Nabilone is combined with Torasemide.


The risk or severity of adverse effects can be increased when Nabilone is combined with citalopram.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Ramelteon.


The risk or severity of adverse effects can be increased when sumatriptan is combined with rasagiline.


The risk or severity of adverse effects can be increased when nortriptyline is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when docetaxel is combined with thalidomide.


The risk or severity of adverse effects can be increased when docetaxel is combined with melphalan.


The risk or severity of adverse effects can be increased when docetaxel is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when bepridil is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when lorazepam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when lorazepam is combined with glutethimide.


The risk or severity of adverse effects can be increased when moclobemide is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when diazepam is combined with triazolam.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Vecuronium.


The risk or severity of adverse effects can be increased when diazepam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when butalbital is combined with felbamate.


The risk or severity of adverse effects can be increased when propoxyphene is combined with trazodone.


The risk or severity of adverse effects can be increased when diazepam is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Salbutamol.


The risk or severity of adverse effects can be increased when DESONIDE is combined with Demecarium.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when butorphanol is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with prilocaine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when spironolactone is combined with enalapril.


The risk or severity of adverse effects can be increased when cabergoline is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when Enasidenib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when cabergoline is combined with Lurasidone.


The risk or severity of adverse effects can be increased when cabergoline is combined with tofisopam.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when metoprolol is combined with cilazapril.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Riociguat.


The risk or severity of adverse effects can be increased when Naftifine is combined with carprofen.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with ambenonium.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Metixene.


The risk or severity of adverse effects can be increased when trandolapril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when trandolapril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with leflunomide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when cilnidipine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with triamcinolone.


The risk or severity of adverse effects can be increased when olanzapine is combined with butamben.


The risk or severity of adverse effects can be increased when niflumic acid is combined with fluocinonide.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when naratriptan is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when promazine is combined with enflurane.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with fluocinonide.


The risk or severity of adverse effects can be increased when mepivacaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when naratriptan is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when naratriptan is combined with thiothixene.


The risk or severity of adverse effects can be increased when nimesulide is combined with Clobetasone.


The risk or severity of adverse effects can be increased when estrone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when propantheline is combined with Vecuronium.


The risk or severity of adverse effects can be increased when propantheline is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with tizanidine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with baclofen.


The risk or severity of adverse effects can be increased when propantheline is combined with pancuronium.


The risk or severity of adverse effects can be increased when nabumetone is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when quazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with RUCAPARIB.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when promethazine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when oxazepam is combined with Paliperidone.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Tixocortol.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with enoxacin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with vinorelbine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with benazepril.


The risk or severity of adverse effects can be increased when tubocurarine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when procyclidine is combined with butorphanol.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when irbesartan is combined with tolmetin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with azathioprine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with fenbufen.


The risk or severity of adverse effects can be increased when leflunomide is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when triprolidine is combined with imipramine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with clidinium.


The risk or severity of adverse effects can be increased when nimodipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when tropicamide is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when isoflurane is combined with trimipramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with procaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when isoflurane is combined with lisinopril.


The risk or severity of adverse effects can be increased when Paliperidone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with benzocaine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when levorphanol is combined with furazolidone.


The risk or severity of adverse effects can be increased when lidocaine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Metixene is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with zopiclone.


The risk or severity of adverse effects can be increased when minocycline is combined with Isotretinoin.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with pancuronium.


The risk or severity of adverse effects can be increased when sevoflurane is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when zopiclone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Vecuronium.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with bumetanide.


The risk or severity of adverse effects can be increased when Halazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when fludiazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with metolazone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with isoetharine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when sumatriptan is combined with perphenazine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with IDARUBICIN.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with procaine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when nimodipine is combined with prazosin.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with dexamethasone.


The risk or severity of adverse effects can be increased when risperidone is combined with brotizolam.


The risk or severity of adverse effects can be increased when Talniflumate is combined with diflunisal.


The risk or severity of adverse effects can be increased when Telmisartan is combined with floctafenine.


The risk or severity of adverse effects can be increased when pentamidine is combined with Pregabalin.


The risk or severity of adverse effects can be increased when thiamylal is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when thiamylal is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with quazepam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with prazepam.


The risk or severity of adverse effects can be increased when prilocaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when methysergide is combined with Imatinib.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when terconazole is combined with lovastatin.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Retigabine.


The risk or severity of adverse effects can be increased when phenylephrine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when meclizine is combined with doxepin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with equilin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with hydralazine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with levodopa.


The risk or severity of adverse effects can be increased when METHAMPHETAMINE is combined with selegiline.


The risk or severity of adverse effects can be increased when butenafine is combined with cinnarizine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Propiverine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with Retigabine.


The risk or severity of adverse effects can be increased when pramipexole is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when isoflurane is combined with HEROIN.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when bromocriptine is combined with papaverine.


The risk or severity of adverse effects can be increased when SAQUINAVIR is combined with oxycodone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with miconazole.


The risk or severity of adverse effects can be increased when Fospropofol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with nifedipine.


The risk or severity of adverse effects can be increased when citalopram is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with difluprednate.


The risk or severity of adverse effects can be increased when dicyclomine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with halcinonide.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Flupentixol.


The risk or severity of adverse effects can be increased when metolazone is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when metolazone is combined with furosemide.


The risk or severity of adverse effects can be increased when metolazone is combined with tizanidine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Propacetamol.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with cilazapril.


The risk or severity of adverse effects can be increased when temazepam is combined with perphenazine.


The risk or severity of adverse effects can be increased when moclobemide is combined with isoproterenol.


The risk or severity of adverse effects can be increased when carisoprodol is combined with clomipramine.


The risk or severity of adverse effects can be increased when metolazone is combined with cilazapril.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with HEROIN.


The risk or severity of adverse effects can be increased when moclobemide is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with acetylcholine.


The risk or severity of adverse effects can be increased when labetalol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when temazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with epoprostenol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with clomipramine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when HEROIN is combined with rasagiline.


The risk or severity of adverse effects can be increased when Eplerenone is combined with Metipranolol.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with thiamylal.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when metolazone is combined with Telmisartan.


The risk or severity of adverse effects can be increased when metolazone is combined with apraclonidine.


The risk or severity of adverse effects can be increased when metolazone is combined with methyldopa.


The risk or severity of adverse effects can be increased when celecoxib is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when D-mannitol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when chloroquine is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with fenoprofen.


The risk or severity of adverse effects can be increased when phenobarbital is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when thiamylal is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with desoximetasone.


The risk or severity of adverse effects can be increased when ramipril is combined with penbutolol.


The risk or severity of adverse effects can be increased when promazine is combined with Melatonin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with cocaine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with ondansetron.


The risk or severity of adverse effects can be increased when pramipexole is combined with lisinopril.


The risk or severity of adverse effects can be increased when nitrazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when pramipexole is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when oxycodone is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Etomidate is combined with HEROIN.


The risk or severity of adverse effects can be increased when oxycodone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with methadone.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Perospirone.


The risk or severity of adverse effects can be increased when prednisone is combined with ambenonium.


The risk or severity of adverse effects can be increased when citalopram is combined with droperidol.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Pirlindole.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Toloxatone.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Tianeptine is combined with methylene blue.


The risk or severity of adverse effects can be increased when meclizine is combined with nefazodone.


The risk or severity of adverse effects can be increased when flunisolide is combined with galanthamine.


The risk or severity of adverse effects can be increased when flunisolide is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when celiprolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when QUINETHAZONE is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when hydralazine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with ethotoin.


The risk or severity of adverse effects can be increased when scopolamine is combined with clomipramine.


The risk or severity of adverse effects can be increased when Bretylium is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with fosinopril.


The risk or severity of adverse effects can be increased when lorazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with tetracaine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with carprofen.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with dantrolene.


The risk or severity of adverse effects can be increased when mecamylamine is combined with quinidine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with nilvadipine.


The risk or severity of adverse effects can be increased when apomorphine is combined with minoxidil.


The risk or severity of adverse effects can be increased when Normethadone is combined with Toloxatone.


The risk or severity of adverse effects can be increased when Normethadone is combined with Pirlindole.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Normethadone is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when Butethal is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Cariprazine.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Caspofungin.


The risk or severity of adverse effects can be increased when sulconazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with estazolam.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with furosemide.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Icatibant.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with tizanidine.


The risk or severity of adverse effects can be increased when temazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Etomidate is combined with Flibanserin.


The risk or severity of adverse effects can be increased when procaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with carisoprodol.


The risk or severity of adverse effects can be increased when ipratropium is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with methadone.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when formestane is combined with mefloquine.


The risk or severity of adverse effects can be increased when quetiapine is combined with efavirenz.


The risk or severity of adverse effects can be increased when MELPERONE is combined with protriptyline.


The risk or severity of adverse effects can be increased when amobarbital is combined with nitrazepam.


The risk or severity of adverse effects can be increased when MELPERONE is combined with cetirizine.


The risk or severity of adverse effects can be increased when betaxolol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when METAXALONE is combined with clidinium.


The risk or severity of adverse effects can be increased when vinorelbine is combined with clozapine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with pilocarpine.


The risk or severity of adverse effects can be increased when pimozide is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when estazolam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when pimozide is combined with bromazepam.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with clonidine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when leflunomide is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when captopril is combined with epirizole.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Icatibant is combined with estrone.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when dibucaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when Caspofungin is combined with diltiazem.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Toloxatone is combined with droxidopa.


The risk or severity of adverse effects can be increased when Lacidipine is combined with morphine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with flunarizine.


The risk or severity of adverse effects can be increased when gabapentin is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with triamcinolone.


The risk or severity of adverse effects can be increased when nimodipine is combined with Bretylium.


The risk or severity of adverse effects can be increased when clorazepate is combined with zopiclone.


The risk or severity of adverse effects can be increased when midazolam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with methyltestosterone.


The risk or severity of adverse effects can be increased when clorazepate is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with procaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with trimipramine.


The risk or severity of adverse effects can be increased when cetirizine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when acemetacin is combined with estrone.


The risk or severity of adverse effects can be increased when diflorasone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Tapentadol.


The risk or severity of adverse effects can be increased when diflorasone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when quetiapine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when pentazocine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when sevoflurane is combined with triflupromazine.


The risk or severity of adverse effects can be increased when celecoxib is combined with fenoprofen.


The risk or severity of adverse effects can be increased when Lacidipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when meperidine is combined with procaine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when clorazepate is combined with Asenapine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when meperidine is combined with trimipramine.


The risk or severity of adverse effects can be increased when propranolol is combined with acebutolol.


The risk or severity of adverse effects can be increased when diclofenac is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with penbutolol.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when oxaprozin is combined with formestane.


The risk or severity of adverse effects can be increased when Trospium is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when tropicamide is combined with butorphanol.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when oxprenolol is combined with butamben.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with loteprednol.


The risk or severity of adverse effects can be increased when mecamylamine is combined with penbutolol.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with streptomycin.


The risk or severity of adverse effects can be increased when Mometasone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when olanzapine is combined with brotizolam.


The risk or severity of adverse effects can be increased when amphotericin b is combined with D-mannitol.


The risk or severity of adverse effects can be increased when indomethacin is combined with triamcinolone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Tixocortol.


The risk or severity of adverse effects can be increased when enflurane is combined with amoxapine.


The risk or severity of adverse effects can be increased when enflurane is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Riociguat is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when benzocaine is combined with clidinium.


The risk or severity of adverse effects can be increased when pimozide is combined with benzocaine.


The risk or severity of adverse effects can be increased when procaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when sertraline is combined with amitriptyline.


The risk or severity of adverse effects can be increased when pimozide is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Tramadol is combined with PAMABROM.


The risk or severity of adverse effects can be increased when ketoprofen is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when alclofenac is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with imipramine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when methylene blue is combined with reserpine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with pilocarpine.


The risk or severity of adverse effects can be increased when isoflurane is combined with flunarizine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with loratadine.


The risk or severity of adverse effects can be increased when Tramadol is combined with lithium ion.


The risk or severity of adverse effects can be increased when pentazocine is combined with dibucaine.


The risk or severity of adverse effects can be increased when trandolapril is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Tramadol is combined with Butethal.


The risk or severity of adverse effects can be increased when pentazocine is combined with metolazone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with tiapride.


The risk or severity of adverse effects can be increased when timolol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with imipramine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with dibucaine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with methyldopa.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with metolazone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when tretinoin is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Pizotifen.


The risk or severity of adverse effects can be increased when diclofenac is combined with salicylic acid.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with apraclonidine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when procaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when methadone is combined with Alvimopan.


The risk or severity of adverse effects can be increased when oxazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when zaleplon is combined with enflurane.


The risk or severity of adverse effects can be increased when decamethonium is combined with acetylcholine.


The risk or severity of adverse effects can be increased when butabarbital is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with loratadine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with procaine.


The risk or severity of adverse effects can be increased when Apremilast is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Naftifine is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when nicergoline is combined with omeprazole.


The risk or severity of adverse effects can be increased when antipyrine is combined with loteprednol.


The risk or severity of adverse effects can be increased when nicergoline is combined with olanzapine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when desipramine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when amitriptyline is combined with scopolamine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with mianserin.


The risk or severity of adverse effects can be increased when scopolamine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when rescinnamine is combined with fenbufen.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Phenelzine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when nicardipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with paramethasone.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with etizolam.


The risk or severity of adverse effects can be increased when Apremilast is combined with Propacetamol.


The risk or severity of adverse effects can be increased when valsartan is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when olanzapine is combined with trazodone.


The risk or severity of adverse effects can be increased when tolmetin is combined with haloperidol.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when dipyridamole is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when nicardipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when glutethimide is combined with levodopa.


The risk or severity of adverse effects can be increased when Escitalopram is combined with periciazine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with selegiline.


The risk or severity of adverse effects can be increased when selegiline is combined with Paliperidone.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with resveratrol.


The risk or severity of adverse effects can be increased when nimesulide is combined with Droxicam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with zotepine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with equilin.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with ibuprofen.


The risk or severity of adverse effects can be increased when amobarbital is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Halazepam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Halazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Remoxipride is combined with glutethimide.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with estrone.


The risk or severity of adverse effects can be increased when Salsalate is combined with Halobetasol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with oxazepam.


The risk or severity of adverse effects can be increased when indomethacin is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Rotigotine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Rotigotine is combined with methyldopa.


The risk or severity of adverse effects can be increased when oxazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when temazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when pimozide is combined with ethotoin.


The risk or severity of adverse effects can be increased when pimozide is combined with prilocaine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with salicylamide.


The risk or severity of adverse effects can be increased when pimozide is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with fludiazepam.


The risk or severity of adverse effects can be increased when oxaprozin is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when glutethimide is combined with loratadine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with fludiazepam.


The risk or severity of adverse effects can be increased when nystatin is combined with nimodipine.


The risk or severity of adverse effects can be increased when clemastine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when quinapril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when tacrolimus is combined with busulfan.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when methadone is combined with amoxapine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when alprazolam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with thiopental.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with zotepine.


The risk or severity of adverse effects can be increased when midazolam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when scopolamine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with HEROIN.


The risk or severity of adverse effects can be increased when Olmesartan is combined with losartan.


The risk or severity of adverse effects can be increased when estazolam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when oxazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when maprotiline is combined with fexofenadine.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when maprotiline is combined with rizatriptan.


The risk or severity of adverse effects can be increased when Sacubitril is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Nepafenac is combined with salicylamide.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when pentazocine is combined with primidone.


The risk or severity of adverse effects can be increased when oxprenolol is combined with triamterene.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Arformoterol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Medroxyprogesterone acetate.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when ramipril is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when diazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when docetaxel is combined with Olaparib.


The risk or severity of adverse effects can be increased when codeine is combined with zotepine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with paroxetine.


The risk or severity of adverse effects can be increased when clozapine is combined with meclizine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when docetaxel is combined with Nintedanib.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with flunarizine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with morphine.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with edrophonium.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with thiopental.


The risk or severity of adverse effects can be increased when Olmesartan is combined with resveratrol.


The risk or severity of adverse effects can be increased when buspirone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Caspofungin is combined with nitrendipine.


The risk or severity of adverse effects can be increased when buspirone is combined with Butethal.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when buspirone is combined with amobarbital.


The risk or severity of adverse effects can be increased when budesonide is combined with leflunomide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with polythiazide.


The risk or severity of adverse effects can be increased when Pirlindole is combined with brimonidine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with diflorasone.


The risk or severity of adverse effects can be increased when pimozide is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when pimozide is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Retigabine is combined with duloxetine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when trazodone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Apremilast.


The risk or severity of adverse effects can be increased when bumetanide is combined with streptomycin.


The risk or severity of adverse effects can be increased when fludiazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when butorphanol is combined with flurazepam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when Remoxipride is combined with amoxapine.


The risk or severity of adverse effects can be increased when butorphanol is combined with tizanidine.


The risk or severity of adverse effects can be increased when Isavuconazole is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with terazosin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when lithium ion is combined with dantrolene.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with nefazodone.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when amcinonide is combined with donepezil.


The risk or severity of adverse effects can be increased when tenoxicam is combined with halcinonide.


The risk or severity of adverse effects can be increased when enflurane is combined with benzocaine.


The risk or severity of adverse effects can be increased when antipyrine is combined with salicylamide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with doxepin.


The risk or severity of adverse effects can be increased when butabarbital is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Articaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Tapentadol is combined with pargyline.


The risk or severity of adverse effects can be increased when Articaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when fosinopril is combined with indapamide.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with clonidine.


The risk or severity of adverse effects can be increased when clidinium is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with HEROIN.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with epirizole.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with penbutolol.


The risk or severity of adverse effects can be increased when midazolam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Propacetamol is combined with equilin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with alprazolam.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Halazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with ethotoin.


The risk or severity of adverse effects can be increased when niflumic acid is combined with triamcinolone.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Normethadone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with sevoflurane.


The risk or severity of adverse effects can be increased when barnidipine is combined with lisinopril.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with furosemide.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with oxycodone.


The risk or severity of adverse effects can be increased when barnidipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when diazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when suprofen is combined with flunisolide.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when diazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when propoxyphene is combined with butalbital.


The risk or severity of adverse effects can be increased when reserpine is combined with alprazolam.


The risk or severity of adverse effects can be increased when ATROPINE is combined with pentazocine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with alclometasone.


The risk or severity of adverse effects can be increased when minoxidil is combined with losartan.


The risk or severity of adverse effects can be increased when docetaxel is combined with Carfilzomib.


The risk or severity of adverse effects can be increased when Etomidate is combined with flunarizine.


The risk or severity of adverse effects can be increased when Retigabine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Tramadol is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when oxazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when Halofantrine is combined with dapsone.


The risk or severity of adverse effects can be increased when Tramadol is combined with linezolid.


The risk or severity of adverse effects can be increased when efavirenz is combined with ethotoin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with rasagiline.


The risk or severity of adverse effects can be increased when oxazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when clozapine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when methylene blue is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with spironolactone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with promazine.


The risk or severity of adverse effects can be increased when meperidine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Normethadone.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with ramipril.


The risk or severity of adverse effects can be increased when paramethasone is combined with mefloquine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with metoprolol.


The risk or severity of adverse effects can be increased when itraconazole is combined with vincristine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when nimodipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Normethadone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when propofol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with amobarbital.


The risk or severity of adverse effects can be increased when barnidipine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when methysergide is combined with paramethasone.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with Demecarium.


The risk or severity of adverse effects can be increased when methysergide is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when brotizolam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Melatonin is combined with imipramine.


The risk or severity of adverse effects can be increased when Pralatrexate is combined with leflunomide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Almotriptan.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with metronidazole.


The risk or severity of adverse effects can be increased when Tolcapone is combined with betaxolol.


The risk or severity of adverse effects can be increased when alclometasone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Repaglinide.


The risk or severity of adverse effects can be increased when Melatonin is combined with loratadine.


The risk or severity of adverse effects can be increased when captopril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when flurazepam is combined with butamben.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with triamcinolone.


The risk or severity of adverse effects can be increased when furosemide is combined with Riociguat.


The risk or severity of adverse effects can be increased when resveratrol is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when enalapril is combined with nimesulide.


The risk or severity of adverse effects can be increased when morphine is combined with protriptyline.


The risk or severity of adverse effects can be increased when dexamethasone is combined with edrophonium.


The risk or severity of adverse effects can be increased when morphine is combined with cetirizine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Fidaxomicin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when celecoxib is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Tixocortol is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when levorphanol is combined with felbamate.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with ILOPROST.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Pipamperone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with ibuprofen.


The risk or severity of adverse effects can be increased when suprofen is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when venlafaxine is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when diazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when olanzapine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when furazolidone is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when Olmesartan is combined with indapamide.


The risk or severity of adverse effects can be increased when Doxercalciferol is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when proparacaine is combined with zotepine.


The risk or severity of adverse effects can be increased when thioridazine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when HEROIN is combined with procarbazine.


The risk or severity of adverse effects can be increased when clozapine is combined with HEROIN.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with tizanidine.


The risk or severity of adverse effects can be increased when azelastine is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Tianeptine.


The risk or severity of adverse effects can be increased when HEROIN is combined with furosemide.


The risk or severity of adverse effects can be increased when HEROIN is combined with tizanidine.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with meperidine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Flupentixol.


The risk or severity of adverse effects can be increased when leflunomide is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with quetiapine.


The risk or severity of adverse effects can be increased when nefazodone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when amobarbital is combined with tiapride.


The risk or severity of adverse effects can be increased when nabumetone is combined with ketoprofen.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with lithium ion.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with fludiazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with etizolam.


The risk or severity of adverse effects can be increased when ATROPINE is combined with methadone.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with paroxetine.


The risk or severity of adverse effects can be increased when desoximetasone is combined with ambenonium.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when oxycodone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when nicardipine is combined with indapamide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when pramipexole is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ibuprofen is combined with estrone.


The risk or severity of adverse effects can be increased when pramipexole is combined with metolazone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with rasagiline.


The risk or severity of adverse effects can be increased when benzocaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when dobutamine is combined with dopamine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when duloxetine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with ethotoin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with isoflurane.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with prilocaine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Propacetamol.


The risk or severity of adverse effects can be increased when fosinopril is combined with Clevidipine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with zotepine.


The risk or severity of adverse effects can be increased when proparacaine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when captopril is combined with sulindac.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when Spirapril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Spirapril is combined with Droxicam.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with rescinnamine.


The risk or severity of adverse effects can be increased when Spirapril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when duloxetine is combined with naratriptan.


The risk or severity of adverse effects can be increased when dapsone is combined with antipyrine.


The risk or severity of adverse effects can be increased when CALCIUM CHLORIDE is combined with Doxercalciferol.


The risk or severity of adverse effects can be increased when thiopental is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with Ephedrine.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when desoximetasone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when isoflurane is combined with cocaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with tiagabine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when enalapril is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when HEROIN is combined with Agomelatine.


The risk or severity of adverse effects can be increased when docetaxel is combined with daunorubicin.


The risk or severity of adverse effects can be increased when triamterene is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Retigabine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Propacetamol.


The risk or severity of adverse effects can be increased when tetracaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when tetracaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when carprofen is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when cabergoline is combined with daunorubicin.


The risk or severity of adverse effects can be increased when cabergoline is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Retigabine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with doxepin.


The risk or severity of adverse effects can be increased when nimesulide is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when halothane is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when bepridil is combined with pravastatin.


The risk or severity of adverse effects can be increased when Escitalopram is combined with MELPERONE.


The risk or severity of adverse effects can be increased when nimesulide is combined with amcinonide.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when HEROIN is combined with cetirizine.


The risk or severity of adverse effects can be increased when HEROIN is combined with protriptyline.


The risk or severity of adverse effects can be increased when Fospropofol is combined with dantrolene.


The risk or severity of adverse effects can be increased when ketamine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with tiagabine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when biperiden is combined with dicyclomine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Alitretinoin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with zonisamide.


The risk or severity of adverse effects can be increased when biperiden is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when amitriptyline is combined with dantrolene.


The risk or severity of adverse effects can be increased when clemastine is combined with meclizine.


The risk or severity of adverse effects can be increased when trandolapril is combined with lisinopril.


The risk or severity of adverse effects can be increased when aspirin is combined with estrone.


The risk or severity of adverse effects can be increased when butamben is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when olanzapine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when azelastine is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when morphine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when azelastine is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with mefloquine.


The risk or severity of adverse effects can be increased when azelastine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when azelastine is combined with Droxicam.


The risk or severity of adverse effects can be increased when furazolidone is combined with Indacaterol.


The risk or severity of adverse effects can be increased when morphine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with sulpiride.


The risk or severity of adverse effects can be increased when primidone is combined with Retigabine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Clobetasone.


The risk or severity of adverse effects can be increased when promazine is combined with glutethimide.


The risk or severity of adverse effects can be increased when Bortezomib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when promazine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with etizolam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with tretinoin.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Nabilone is combined with nimodipine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with quetiapine.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with prednisone.


The risk or severity of adverse effects can be increased when promazine is combined with dibucaine.


The risk or severity of adverse effects can be increased when glutethimide is combined with Articaine.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with levorphanol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with niflumic acid.


The risk or severity of adverse effects can be increased when buspirone is combined with perphenazine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when spironolactone is combined with acebutolol.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Apremilast.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Deferasirox.


The risk or severity of adverse effects can be increased when oxycodone is combined with lithium ion.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Phenelzine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when pergolide is combined with Quinupristin.


The risk or severity of adverse effects can be increased when lorazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with Demecarium.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Olsalazine.


The risk or severity of adverse effects can be increased when valsartan is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Miltefosine is combined with isradipine.


The risk or severity of adverse effects can be increased when valsartan is combined with lisinopril.


The risk or severity of adverse effects can be increased when rapamycin is combined with nicardipine.


The risk or severity of adverse effects can be increased when suprofen is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when methysergide is combined with cabergoline.


The risk or severity of adverse effects can be increased when glutethimide is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when gabapentin is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when methysergide is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when perphenazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when apomorphine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when methysergide is combined with RANOLAZINE.


The risk or severity of adverse effects can be increased when estrone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Escitalopram.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Tolcapone.


The risk or severity of adverse effects can be increased when procyclidine is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when oxazepam is combined with lithium ion.


The risk or severity of adverse effects can be increased when sulindac is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when sevoflurane is combined with methocarbamol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with spironolactone.


The risk or severity of adverse effects can be increased when linezolid is combined with quetiapine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with triprolidine.


The risk or severity of adverse effects can be increased when Naftifine is combined with halcinonide.


The risk or severity of adverse effects can be increased when codeine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when secobarbital is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when methylergonovine is combined with mefloquine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Butethal is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when secobarbital is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when secobarbital is combined with triazolam.


The risk or severity of adverse effects can be increased when brimonidine is combined with terazosin.


The risk or severity of adverse effects can be increased when sulindac is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when pentazocine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when sulindac is combined with amcinonide.


The risk or severity of adverse effects can be increased when tizanidine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with equilin.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when phenylephrine is combined with celiprolol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with HEROIN.


The risk or severity of adverse effects can be increased when prilocaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with betamethasone.


The risk or severity of adverse effects can be increased when Melatonin is combined with paroxetine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when ethotoin is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when loxapine is combined with quazepam.


The risk or severity of adverse effects can be increased when loxapine is combined with prazepam.


The risk or severity of adverse effects can be increased when Melatonin is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when anagrelide is combined with Olsalazine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with epirizole.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with triamcinolone.


The risk or severity of adverse effects can be increased when morphine is combined with zotepine.


The risk or severity of adverse effects can be increased when griseofulvin is combined with ethanol.


The risk or severity of adverse effects can be increased when rasagiline is combined with Salmeterol.


The risk or severity of adverse effects can be increased when rasagiline is combined with mesoridazine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Torasemide.


The risk or severity of adverse effects can be increased when rasagiline is combined with maprotiline.


The risk or severity of adverse effects can be increased when triamterene is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when vigabatrin is combined with citalopram.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with cetirizine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when penbutolol is combined with nicotine.


The risk or severity of adverse effects can be increased when penbutolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when lidocaine is combined with Etomidate.


The risk or severity of adverse effects can be increased when proparacaine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when doxylamine is combined with duloxetine.


The risk or severity of adverse effects can be increased when doxylamine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when temazepam is combined with meprobamate.


The risk or severity of adverse effects can be increased when tenoxicam is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with salicylamide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when amobarbital is combined with Milnacipran.


The risk or severity of adverse effects can be increased when salicylamide is combined with paramethasone.


The risk or severity of adverse effects can be increased when spironolactone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when halothane is combined with Fospropofol.


The risk or severity of adverse effects can be increased when salicylamide is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when ATROPINE is combined with oxycodone.


The risk or severity of adverse effects can be increased when halothane is combined with nilvadipine.


The risk or severity of adverse effects can be increased when apomorphine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Mersalyl.


The risk or severity of adverse effects can be increased when Butethal is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with carvedilol.


The risk or severity of adverse effects can be increased when sulindac is combined with diflunisal.


The risk or severity of adverse effects can be increased when dyclonine is combined with citalopram.


The risk or severity of adverse effects can be increased when oxazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when apomorphine is combined with methyldopa.


The risk or severity of adverse effects can be increased when mecamylamine is combined with codeine.


The risk or severity of adverse effects can be increased when valsartan is combined with rescinnamine.


The risk or severity of adverse effects can be increased when desipramine is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with nalbuphine.


The risk or severity of adverse effects can be increased when loxapine is combined with baclofen.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with clopidogrel.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with antipyrine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Mometasone.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with pimozide.


The risk or severity of adverse effects can be increased when clidinium is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when loxapine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with epinastine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when cilazapril is combined with leflunomide.


The risk or severity of adverse effects can be increased when alprazolam is combined with quetiapine.


The risk or severity of adverse effects can be increased when nifedipine is combined with Riociguat.


The risk or severity of adverse effects can be increased when glutethimide is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when sertraline is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when methadone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when amobarbital is combined with thiothixene.


The risk or severity of adverse effects can be increased when amobarbital is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with tizanidine.